🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

30,67 USD

Máx. histórico

61,25

1782 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-49,93%

Rango 52 semanas

23,62 – 31,04

Variación hoy

+0,49%

Cierre anterior

30,52

Rango de hoy

30,20 – 31,04

Volumen hoy

49.839.061

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,32%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
40,36 (puede no estar actualizado)
Dividend yield
5,64% (puede no estar actualizado)
Precio objetivo analistas
29,26 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 18 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,61%
Fecha de pago Importe por participación
07/11/2007 0,2751 USD
08/08/2007 0,2751 USD
09/05/2007 0,2751 USD
07/02/2007 0,2751 USD
08/11/2006 0,2277 USD
09/08/2006 0,2277 USD
10/05/2006 0,2277 USD
08/02/2006 0,2277 USD
08/11/2005 0,1803 USD
10/08/2005 0,1803 USD
11/05/2005 0,1803 USD
09/02/2005 0,1803 USD
09/11/2004 0,1613 USD
11/08/2004 0,1613 USD
12/05/2004 0,1613 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/03/2026 27,42 27,82 27,15 27,77 +2,70% 2,44% 46.696.000
27/03/2026 27,73 27,77 27,02 27,04 -1,92% 2,70% 29.124.600
26/03/2026 27,25 27,81 27,24 27,57 +1,06% 2,09% 28.835.000
25/03/2026 27,18 27,53 27,04 27,28 +1,19% 1,80% 37.603.900
24/03/2026 26,60 27,13 26,44 26,96 +0,71% 2,59% 35.605.300
23/03/2026 27,03 27,19 26,63 26,77 -0,74% 2,07% 42.945.200
20/03/2026 27,41 27,55 26,80 26,97 -1,61% 2,74% 66.805.700
19/03/2026 27,29 27,73 27,25 27,41 +0,33% 1,76% 47.939.600
18/03/2026 27,14 27,38 26,84 27,32 -0,47% 1,99% 47.478.300
17/03/2026 26,82 27,76 26,82 27,45 +3,16% 3,50% 60.097.500
16/03/2026 26,70 26,89 26,52 26,61 +0,11% 1,39% 28.551.500
13/03/2026 27,02 27,28 26,58 26,58 -1,04% 2,59% 34.270.800
12/03/2026 27,11 27,12 26,63 26,86 -1,61% 1,81% 38.542.800
11/03/2026 27,20 27,41 27,00 27,30 +0,52% 1,51% 40.560.100
10/03/2026 26,82 27,29 26,52 27,16 +1,31% 2,87% 42.814.600
09/03/2026 26,91 27,11 26,36 26,81 -0,89% 2,79% 42.789.500
06/03/2026 26,54 27,13 26,23 27,05 +1,65% 3,39% 53.181.800
05/03/2026 26,39 26,71 26,20 26,61 -0,04% 1,93% 38.908.600
04/03/2026 26,77 26,78 26,35 26,62 +0,15% 1,61% 30.893.500
03/03/2026 26,72 26,95 26,35 26,58 -2,49% 2,25% 41.486.100
02/03/2026 27,57 27,61 27,17 27,26 -1,41% 1,60% 41.321.700
27/02/2026 27,16 27,67 27,09 27,65 +2,03% 2,14% 41.879.700
26/02/2026 27,26 27,27 26,87 27,10 +0,04% 1,47% 30.508.300
25/02/2026 27,06 27,29 26,73 27,09 -0,18% 2,07% 32.680.300
24/02/2026 27,14 27,42 27,08 27,14 +0,30% 1,25% 34.686.100
23/02/2026 26,56 27,11 26,50 27,06 +1,54% 2,30% 34.166.100
20/02/2026 26,71 26,78 26,36 26,65 -0,78% 1,57% 44.786.900
19/02/2026 27,37 27,40 26,58 26,86 -1,86% 3,00% 40.316.800
18/02/2026 27,44 27,48 27,21 27,37 +0,00% 0,98% 24.779.800
17/02/2026 27,84 27,87 27,20 27,37 -0,76% 2,41% 32.119.900